Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Pons connectivity correlates with neurophysiological and clinical signatures of predictive coding in psychosis
    Published on 2024-07-22
    2 years ago
  • Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression
    Published on 2024-07-22
    2 years ago
  • Neuroimaging for precision medicine in psychiatry
    Published on 2024-07-22
    2 years ago
  • Environmental and neurodevelopmental contributors to youth mental illness
    Published on 2024-07-19
    2 years ago
  • Neuroimaging education in psychiatric training
    Published on 2024-07-18
    2 years ago
  • Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics
    Published on 2024-07-18
    2 years ago
  • Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity
    Published on 2024-07-18
    2 years ago
« Previous 1 … 82 83 84 85 86 … 143 Next »
Journal of Psychopharmacology
  • A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium” by Vázquez et al. (Journal of Psychopharmacology, 2021, Vol. 35(8) 890–900)
    Published on 2022-04-27
    4 years ago
  • Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway
    Published on 2022-04-27
    4 years ago
  • Acute treatment with 5-hydroxytryptophan increases social approach behaviour but does not activate serotonergic neurons in the dorsal raphe nucleus in juvenile male BALB/c mice: A model of human disorders with deficits of sociability
    Published on 2022-04-27
    4 years ago
  • Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences
    Published on 2022-04-27
    4 years ago
  • A theory of the anxiolytic action of flumazenil in anxiety disorders
    Published on 2022-04-27
    4 years ago
  • The cortical silent period in schizophrenia: A systematic review and meta-analysis focusing on disease stage and antipsychotic medication
    Published on 2022-04-27
    4 years ago
  • Catechol-O-methyltransferase activity does not influence emotional processing in men
    Published on 2022-04-21
    4 years ago
« Previous 1 … 82 83 84 85 86 … 150 Next »
European Neuropsychopharmacology
  • The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders
    Published on 2022-07-24
    4 years ago
  • Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”
    Published on 2022-07-24
    4 years ago
  • New antidepressants: New day or false dawn?
    Published on 2022-07-23
    4 years ago
  • Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism
    Published on 2022-07-23
    4 years ago
  • Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment
    Published on 2022-07-11
    4 years ago
  • Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder
    Published on 2022-07-08
    4 years ago
  • Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
    Published on 2022-07-08
    4 years ago
« Previous 1 … 82 83 84 85 86 … 168 Next »

   Pharma Pub